The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.
Psychological Medicine November 2023 Matthew N Hill, Margaret Haney, Cecilia J. Hillard et al.
Cannabis is well established to impact affective states, emotion and perceptual processing, primarily through its interactions with the endocannabinoid system. While cannabis use is quite prevalent in many individuals afflicted with psychiatric illnesses, there is considerable controversy as to whether cannabis may worsen these conditions or provide some form of therapeutic benefit. The...